Publication | Closed Access

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial

Hematological MalignancyOncologyMalignant Blood DisorderHematologyConsolidation TherapyArsenic TrioxideRemission InductionMedicineRadiation OncologyCancer ResearchHealth Sciences